Our Team | INNOCARE

Executive Team

Jasmine Cui Ph.D.

Co-Founder Chairwoman and CEO

Founder’s Message

We founded InnoCare with the mission of saving and empowering lives by enabling patient’s access to the finest innovative drugs. As visionaries and trailblazers in the biopharmaceutical sector, we uphold the philosophy of ‘Science Drives Innovation for the Benefit of Patients’, dedicating ourselves to creating innovative drugs for cancer and autoimmune diseases. Recognizing that talent is the bedrock of biopharmaceutical innovation, InnoCare has always put talent at the top of its corporate development agenda. With a high-caliber talent team and top-tier innovation capabilities, we believe that InnoCare is well on track to become a world-class pharmaceutical company.

— Jasmine Cui Ph.D.

Xiangyang Chen Ph.D.

CTO

Kevin Gao Ph.D.

COO

Mr. Xin Fu

CFO

Mr. Jeff Chen

CCO

Weimin Tang Ph.D.

CBO

Richard Liu Ph.D.

Vice President of Biology

Charles Y. Wang Ph.D., DABT

Vice President of Drug Safety & DMPK

Renbin Zhao Ph.D.

Vice President of Clinical Development and Medical Research

Norman Kong Ph.D.

Vice President of Medicinal Chemistry

Boyan Zhang Ph.D.

Vice President of Biologics CMC

Carrie Zhou Ph.D.

Vice President of Medical Research

Jessie Wang

General Counsel

Scientific Advisory Board

Yigong Shi Ph.D.

InnoCare Co-founder & President of SAB

Founder’s Message

As China emerges as a formidable biopharmaceutical force, we've advanced in our capabilities, moving from producing best-in-class drugs to pioneering first-in-class medicines. We hope to independently develop more innovative drugs. Our innovation is fueled by an unwavering vision to improve human well-being, a goal which through our collective efforts is gradually becoming a reality.

— Yigong Shi Ph.D.